Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Meloxicam sodium
Drug ID BADD_D01375
Description Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve various types of pain, including pain caused by musculoskeletal conditions, osteoarthritis, and rheumatoid arthritis.[A190189] With a longer half-life than most other NSAIDS, it is a favorable option for those who require once-daily dosing. Meloxicam is available in oral, transdermal, and intravenous formulations. It is a preferential COX-2 inhibitor, purportedly reducing the risk of adverse gastrointestinal tract effects, however, this is a topic of controversy.[A190198,A190201]
Indications and Usage For symptomatic treatment of arthritis and osteoarthritis.
Marketing Status Prescription; Discontinued
ATC Code M01AC06
DrugBank ID DB00814
KEGG ID D00969
MeSH ID D000077239
PubChem ID 4051
TTD Drug ID D0G7FJ
NDC Product Code 0597-0030; 22365-116; 0615-8124; 51869-0008; 43063-396; 50090-5861; 54458-965; 60760-419; 61442-127; 63187-083; 63629-2019; 65841-051; 65862-098; 67296-1250; 68071-1994; 68071-2184; 68071-3030; 68382-050; 68382-051; 70518-0031; 71610-544; 80425-0041; 52119-003; 16571-776; 35356-808; 50090-5339; 50436-1124; 65841-050; 68071-1919; 68071-4987; 68788-7726; 68788-7904; 70518-0171; 71205-923; 71205-924; 29300-124; 50090-0986; 50268-526; 51655-577; 53002-1535; 53002-1537; 58118-1158; 63629-2020; 68788-9418; 70518-3023; 70934-010; 70954-077; 71610-516; 71610-580; 72865-137; 76282-153; 51552-1377; 53069-0790; 53104-7574; 43353-038; 43353-979; 55289-618; 61919-434; 61919-469; 64380-715; 64380-716; 71335-1956; 0597-0029; 49452-4402; 65862-223; 16571-777; 42708-007; 43063-395; 51407-611; 53002-2537; 61442-126; 67296-0583; 68180-501; 68180-502; 69097-158; 69097-159; 69344-206; 71335-0406; 71335-1888; 76420-039; 76420-043; 80425-0083; 0395-8154; 68225-112; 29300-125; 43063-401; 49999-869; 50268-525; 50436-1125; 60760-404; 60760-448; 63629-3248; 63629-3328; 67296-1317; 68071-1993; 68180-188; 70518-1828; 71335-1618; 71518-001; 17373-1157; 0615-8040; 56125-750; 65841-004; 70859-007; 55289-272; 63187-082; 68462-140; 70518-1299; 80425-0043; 80425-0045; 51927-0032; 59349-0003; 43353-127; 50090-5340; 51407-610; 51655-731; 60687-199; 68462-141; 69344-205; 70518-0039; 70518-0200; 71610-380; 71610-542; 71610-583; 72865-138; 80425-0042; 80425-0044; 17373-1158; 38779-2746; 58624-0430; 60592-994; 62938-0026; 68981-032; 42708-093; 50090-0985; 65862-097; 67296-1817; 68788-1701; 70954-076; 76282-152; 51869-0007; 53747-006; 72969-045; 45865-360; 50090-4896; 53002-2535; 54458-964; 63629-7966; 67296-0823; 68180-189; 70518-2631
Synonyms Meloxicam | Miloxicam | Parocin | Mobic | Mobicox | Mobec | Masflex | Movicox | Reumoxicam | Uticox | Movalis
Chemical Information
Molecular Formula C14H12N3NaO4S2
CAS Registry Number 71125-38-7
SMILES CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)[O-].[Na+]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Eye disorder06.08.03.001--Not Available
Face oedema23.04.01.004; 10.01.05.002; 08.01.07.003--
Fatigue08.01.01.002--
Feeling abnormal08.01.09.014--Not Available
Flatulence07.01.04.002--
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Gamma-glutamyltransferase increased13.03.01.011--
Gastric ulcer07.04.03.002--
Gastric ulcer perforation07.04.03.006--Not Available
Gastritis07.08.02.001--
Gastrooesophageal reflux disease07.02.02.003--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal haemorrhage24.07.02.009; 07.12.02.001--Not Available
Gastrointestinal pain07.01.05.005--
Gastrointestinal perforation07.04.04.001--Not Available
Gravitational oedema08.01.07.005; 02.05.04.014--Not Available
Haematemesis07.12.02.002; 24.07.02.011--Not Available
Haematuria24.07.01.047; 20.02.01.006--
Haemoglobin13.01.05.018--Not Available
Headache17.14.01.001--
Hepatic failure09.01.03.002--
Hepatic function abnormal09.01.02.001--Not Available
Hepatitis09.01.07.004--Not Available
Hyperbilirubinaemia14.11.01.010; 09.01.01.003; 01.06.04.003--Not Available
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypotension24.06.03.002--
Immune system disorder10.02.01.001--Not Available
Increased appetite14.03.01.003; 08.01.09.027--Not Available
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 7 Pages